In Vitro Fertilization: Clinical Trials

9 trials for In Vitro Fertilization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 1 recruiting. 9 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 5, Unknown 3, Recruiting 1
Phase 22Unknown 2

Follow In Vitro Fertilization: new trials by email Literature Review of In Vitro Fertilization trials Research Report on In Vitro Fertilization

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles
Ovulation induction with hCG + Luteal phase support with vaginal progesterone, Ovulation triggering by Triptorelin + Luteal phase support by Nafarelin - In Vitro Fertilization, ICSI Intracytoplasmic Spermatozoid Injection
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris6522024-06-272025-08-24
What Amount of Stress is Enough for a Successful Conception?
Midazolam 7.5mg - In Vitro Fertilization, Stress
Phase 3UnknownUniversity Hospital Sestre Milosrdnice402019-09-012019-11-13
Impact of Melatonin on IVF/ICSI Outcomes in Prospective Poor Responders
Melatonin, Placebo - In Vitro Fertilization, Poor Ovarian Response
Phase 2 / Phase 3UnknownAssiut University1002016-12-012016-12-15
Can Calcium Ionophore Application Enhance the ICSI Outcomes in Severe Male Factor Infertility?
Ca Ionophore A23187, Placebo - In Vitro Fertilization, Male Factor Infertility
Phase 2 / Phase 3UnknownAssiut University1002016-12-012016-12-14
Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity
recombinant hCG, urinary hCG - In Vitro Fertilization
Phase 3CompletedRoyan Institute1802010-10-012014-04-25
Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)
Progesterone - In Vitro Fertilization
Phase 3CompletedIBSA Institut Biochimique SA6832009-01-012013-01-31
Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF)
Progesterone - In Vitro Fertilization
Phase 3CompletedIBSA Institut Biochimique SA8002008-12-012013-01-31
Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)
Corifollitropin alfa, FSH, GnRH antagonist - In Vitro Fertilization
Phase 3CompletedOrganon and Co6822006-09-262024-06-18
A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)
Corifollitropin alfa, RecFSH / Follitropin beta (Days 1 to 7), Placebo Corifollitropin alfa - In Vitro Fertilization
Phase 3CompletedOrganon and Co15092006-06-272024-06-20

Narrower conditions

Infertility (2)  ·  Stress, Psychological (1)

Broader conditions

Genital Diseases (2)  ·  Urogenital Diseases (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)

Interventions

Progesterone (4)  ·  Chorionic Gonadotropin (2)  ·  follicle stimulating hormone, human, with HCG C-terminal peptide (2)  ·  Glycoprotein Hormones, alpha Subunit (1)  ·  LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1)  ·  Melatonin (1)  ·  Midazolam (1)  ·  Ovulation Induction (1)  ·  follitropin beta (1)  ·  ganirelix (1)

Sponsors

Assiut University (2)  ·  IBSA Institut Biochimique SA (2)  ·  Organon and Co (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Royan Institute (1)  ·  University Hospital Sestre Milosrdnice (1)

Countries

Egypt (2)  ·  Croatia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Iran (1)  ·  Italy (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Hamid Gourabi, PhD (1)  ·  Osama Abdalmageed (1)  ·  Osama Abdalmageed, MD (1)  ·  Taraneh Madani, MD (1)

Results publications

PMID 26950065, PMID 26991902, PMID 30895243, PMID 19684043, PMID 20843746, PMID 21622693, PMID 23274511, PMID 23758821, PMID 24140033, PMID 24903202, PMID 25100106, PMID 26187300, PMID 27619773

NIH funding

2004 (2)